Abstract

Evidence indicates that poor glycemic control is associated with increased morbidity and length of stay in hospital. There are a wide range of guidelines published, which seek to ensure safe and effective inpatient glycemic control in the hospital setting. However, the implementation of these protocols is limited in practice. In particular, the feasibility of "flash" and continuous glucose monitoring (CGM) remains untested on general wards. Scoping Review. If used in the general ward hospital settings, CGM and flash glucose monitoring (FGM) systems could lead to improved glycemic control, decreased length of stay, and reduced risk of severe hypoglycemia or hyperglycemia. Potential problems include lack of experience with this technology and costs of sensors. Rapid analysis of glucose measurements can facilitate clinical decision making and therapy adjustment in the hospital setting. In addition, people with diabetes may be empowered to better self-manage their condition in hospital as they have direct access to their glucose data. More studies are required in which the feasibility, benefits and limitations of FGM and CGM in non-intensive care unit hospital settings are elucidated. We need evidence on which types of hospital wards might benefit from the introduction of this technology and the contexts in which they are less useful. We also need to identify the types of people who are most likely to find FGM and CGM useful for self-management and for which populations they have the most benefit in terms of clinical outcomes and length of stay.

Highlights

  • The growing prevalence of diabetes across the world and the demand for elective and unscheduled hospital admissions resulting from diabetes complications mean a high percentage of hospital inpatients require sustained glucose monitoring.[1,2] Poor glycemic control in hospital is associated with adverse clinical outcomes and increased length of stay.[3,4] A high incidence of inpatient hyperglycemia and hypoglycemia represents a significant financial and practical burden for service users, health care providers, and their families and carers.[5]Diabetes technology has progressed greatly over the past decade.[6]

  • More studies are required in which the feasibility, benefits and limitations of flash glucose monitoring (FGM) and continuous glucose monitoring (CGM) in non–intensive care unit hospital settings are elucidated

  • We need to identify the types of people who are most likely to find FGM and CGM useful for self-management and for which populations they have the most benefit in terms of clinical outcomes and length of stay

Read more

Summary

Introduction

The growing prevalence of diabetes across the world and the demand for elective and unscheduled hospital admissions resulting from diabetes complications mean a high percentage of hospital inpatients require sustained glucose monitoring.[1,2] Poor glycemic control in hospital is associated with adverse clinical outcomes and increased length of stay.[3,4] A high incidence of inpatient hyperglycemia and hypoglycemia represents a significant financial and practical burden for service users, health care providers, and their families and carers.[5]. Diabetes technology has progressed greatly over the past decade.[6] Advances in glucose monitoring and insulin delivery systems have improved clinical outcomes and quality of life for people with type 1 diabetes (T1D) in the outpatient setting. The feasibility of “flash” and continuous glucose monitoring (CGM) remains untested on general wards

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call